Ophthotech Corporation to Report Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, July 26, 2017
July 21 2017 - 7:30AM
Business Wire
Ophthotech Corporation (Nasdaq:OPHT) today announced that it
will report its second quarter 2017 financial and operating results
on Wednesday, July 26, 2017. Following the announcement,
Ophthotech’s management team will host a live conference call and
webcast at 8:00 a.m. Eastern Time to discuss the Company’s
financial results and provide a business update.
To participate in this conference call, dial 888-280-4443 (USA)
or 719-457-2603 (International), passcode 8248330. A live,
listen-only audio webcast of the conference call can be accessed on
the Investor Relations section of the Ophthotech website at:
www.ophthotech.com. A replay will be available approximately two
hours following the live call for two weeks. The replay number is
888-203-1112 (USA Toll Free), passcode 8248330.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of novel therapeutics for diseases of the eye. For more
information, please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release
about Ophthotech's future expectations, plans and
prospects constitute forward-looking statements for purposes of the
safe harbor provisions under the Private Securities Litigation
Reform Act of 1995. Actual results may differ materially from those
indicated by such forward-looking statements as a result of various
important factors. Any forward-looking statements
represent Ophthotech's views only as of the date of this
press release. Ophthotech anticipates that subsequent
events and developments will cause its views to change.
While Ophthotech may elect to update these
forward-looking statements at some point in the
future, Ophthotech specifically disclaims any obligation
to do so.
OPHT-G
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170721005076/en/
Ophthotech CorporationInvestorsKathy Galante,
212-845-8231Vice President, Investor Relations and Corporate
Communicationskathy.galante@ophthotech.comorMediaSmithSolve
LLC on behalf of Ophthotech CorporationAlex Van Rees, 973-442-1555
ext. 111alex.vanrees@smithsolve.com
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Aug 2024 to Sep 2024
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Sep 2023 to Sep 2024